NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 279 filers reported holding NEOGENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $179,807 | +7.0% | 11,189 | -42.5% | 0.00% | – |
| Q3 2022 | $168,000 | -21.5% | 19,476 | -25.8% | 0.00% | – |
| Q2 2022 | $214,000 | -47.7% | 26,254 | -22.0% | 0.00% | – |
| Q1 2022 | $409,000 | -78.2% | 33,667 | -38.8% | 0.00% | -100.0% |
| Q4 2021 | $1,876,000 | -28.3% | 54,995 | +1.4% | 0.00% | 0.0% |
| Q3 2021 | $2,616,000 | -18.8% | 54,228 | -24.0% | 0.00% | -33.3% |
| Q2 2021 | $3,222,000 | +24.4% | 71,328 | +32.8% | 0.00% | 0.0% |
| Q1 2021 | $2,590,000 | -28.5% | 53,707 | -20.2% | 0.00% | -25.0% |
| Q4 2020 | $3,623,000 | +49.0% | 67,299 | +2.1% | 0.00% | +33.3% |
| Q3 2020 | $2,432,000 | +14.8% | 65,936 | -3.6% | 0.00% | 0.0% |
| Q2 2020 | $2,118,000 | -20.9% | 68,373 | -29.5% | 0.00% | -25.0% |
| Q1 2020 | $2,677,000 | +1.1% | 96,966 | +7.1% | 0.00% | +33.3% |
| Q4 2019 | $2,648,000 | +103.5% | 90,546 | +33.1% | 0.00% | +50.0% |
| Q3 2019 | $1,301,000 | +26.9% | 68,053 | +45.7% | 0.00% | +100.0% |
| Q2 2019 | $1,025,000 | +17.7% | 46,716 | +9.7% | 0.00% | 0.0% |
| Q1 2019 | $871,000 | +69.1% | 42,572 | +4.2% | 0.00% | 0.0% |
| Q4 2018 | $515,000 | +340.2% | 40,856 | +289.7% | 0.00% | – |
| Q3 2017 | $117,000 | – | 10,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 396,327 | $8,109,000 | 6.56% |
| Cowen Prime Services LLC | 584,766 | $11,964,000 | 6.20% |
| 1492 Capital Management LLC | 269,488 | $5,514,000 | 4.67% |
| First Light Asset Management, LLC | 1,604,611 | $32,830,000 | 4.27% |
| PERKINS CAPITAL MANAGEMENT INC | 264,650 | $5,415,000 | 3.56% |
| FALCON POINT CAPITAL, LLC | 219,992 | $4,501,000 | 2.45% |
| Granite Investment Partners, LLC | 1,764,090 | $36,093,000 | 2.05% |
| Ranger Investment Management | 1,209,535 | $24,747,000 | 1.79% |
| EMERALD ADVISERS, LLC | 1,878,901 | $38,442,000 | 1.56% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,875,759 | $38,378,000 | 1.54% |